Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function

Abstract

ObjectivesProperties of mesenchymal stromal/stem cells (MSCs) from systemic sclerosis (SSc) patients have been reported to be altered. MSC-based therapy may therefore rely on the use of allogeneic MSCs from healthy subjects. Here, we investigated whether heterologous MSCs could exhibit altered properties following exposure to oxidative environment of SSc sera.MethodsHuman bone marrow-derived MSCs were cultured in the presence of various sera: control human serum AB (SAB), SAB with HOCl-induced AOPPs at 400 or 1,000 µmol/L (SAB400 or SAB1000, respectively), or H2O2-induced AOPPs or SSc patient serum (PS). Proliferation, apoptosis, and senescence rates of MSCs were evaluated after 3, 6, and 10 days in culture. Reactive oxygen species and nitric oxide production were quantified at 24 h. Trilineage potential of differentiation was tested after 21 days in specific culture conditions and immunosuppressive function measured in a T lymphocyte proliferative assay.ResultsIn the presence of oxidative environment of PS, MSCs retained their proliferative potential and survived for at least the first 3 days of exposure, while the number of senescent MSCs increased at day 6 and apoptosis rate at day 10. Exposure to PS enhanced the antioxidant capacity of MSCs, notably the expression of SOD2 antioxidant gene. By contrast, the osteoblastic/adipogenic potential of MSCs was increased, whereas their immunosuppressive function was slightly reduced.DiscussionAlthough some functional properties of MSCs were affected upon culture with PS, evidence from preclinical studies and the present one suggested that MSCs can adapt to the oxidative environment and exert their therapeutic effect.

Sustained curcumin release from PLGA microspheres improves bone formation under diabetic conditions by inhibiting the reactive oxygen species production

“… 7 , 8 The increased oxidative stress resulting from excessive ROS causes damage to macromolecular substances (nucleic acids and lipids), induces mesenchymal stem cells (MSCs) apoptosis, and delays their osteogenic differentiation. 9 , 10 In line with these findings, scavenging ROS with antioxidant remarkably can protect MSCs from oxidative injury and reverse the negative effect of type 2 diabetes mellitus on bone formation. 11 …”

Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis

“…The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01. disease development 19,20 . These findings together implied pathogenic roles for the morbid serum environment and MSCs senescence in autoimmune diseases.…”

“…It has been reported that senescent MSCs display a senescence-associated secretory phenotype (SASP), an impaired immunomodulatory function and aberrant differentiation capability 17,18 . Furthermore, in some autoimmune diseases such as systemic lupus erythematosus (SLE) 19 and systemic sclerosis (SSc) 20 , MSCs senescence is induced by the patient's serum and participates in disease development. However, whether a similar situation exists in AS remains unclear.…”

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis

“…Briefly, 2.5 Â 10 5 BM-MSCs were centrifuged in 15 mL conical tubes and cultured in DMEM high glucose (Lonza, Levallois) with 100 mg/mL penicillin/streptomycin, 0.35 mM proline, 0.1 mM dexamethasone, 0.17 mM ascorbic acid-2phosphate, 1 mM pyruvate sodium, 1% insulin-transferrin-selenic acid (Lonza) and 10 ng/mL TGF-b3 or 100 ng/mL BMP-2 or IGF-1 (R&D Systems). BM-MSCs were differentiated towards osteoblasts or adipocytes by culture in inductive conditions for 21 days as described 15 .…”